摘要
美国政府生命科学两用性研究监管政策可以有效地管理误用科学研究周期产生的风险,但是有待于进一步完善。两用性研究存在不可靠甚至矛盾的问题,其监管困难重重。美国高危病原体研究监管主要依靠生命科学团体的自我管理;加强禽流感病毒研究监管已经成为国际共识,美国注重实验室意外释放和故意谬用的双重风险;本研究通过文献调研、情报追踪、系统分析和经典案例法,对美国政府研究监管措施进行了系统梳理与分析,探讨禽流感病毒等高危病原体研究发展和监管趋势。
Although the policy for oversight of life sciences dual use research, released by the US government, can manage the risks of potential misuse throughout the research lifecycle effectively, it need to be further improved. There were the existence of unreliable or even contradictory problem and the regulatory difficulties about dual use research. In the USA, the oversight of status quo mainly relies on self-governance in the scientific community. There is the international consensus on the increase of oversight of high-consequence pathogens research, which paid more attention to the dual risk of laboratory accidental release and deliberate misuse about high-consequence pathogens research in the United States. We performed literature retrieval, information tracking, comprehensive analysis and typical case analysis, and reviewed and analyzed the United States Government measures to discuss the future and oversight of high-conse- quence pathogens research by analyzing the policies.
出处
《中国医药导报》
CAS
2015年第35期153-156,168,共5页
China Medical Herald
关键词
禽流感病毒
高危病原体
研究监管
管理措施
Avian influenza virus
High-consequence pathogens
Research oversight
Management measures
